FI940726A0 - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
FI940726A0
FI940726A0 FI940726A FI940726A FI940726A0 FI 940726 A0 FI940726 A0 FI 940726A0 FI 940726 A FI940726 A FI 940726A FI 940726 A FI940726 A FI 940726A FI 940726 A0 FI940726 A0 FI 940726A0
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
water
hirudin
magnesium
calcium
Prior art date
Application number
FI940726A
Other languages
English (en)
Finnish (fi)
Other versions
FI940726A (sv
Inventor
Tudor Arvinte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI940726A0 publication Critical patent/FI940726A0/sv
Publication of FI940726A publication Critical patent/FI940726A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
FI940726A 1993-02-18 1994-02-16 Farmaceutiska kompositioner FI940726A (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303275A GB9303275D0 (en) 1993-02-18 1993-02-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI940726A0 true FI940726A0 (sv) 1994-02-16
FI940726A FI940726A (sv) 1994-08-19

Family

ID=10730651

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940726A FI940726A (sv) 1993-02-18 1994-02-16 Farmaceutiska kompositioner

Country Status (21)

Country Link
US (1) US5472938A (sv)
EP (1) EP0624375B1 (sv)
JP (1) JP3649343B2 (sv)
CN (1) CN1108137A (sv)
AT (1) ATE216586T1 (sv)
AU (1) AU675471B2 (sv)
CA (1) CA2115815A1 (sv)
DE (1) DE69430458T2 (sv)
DK (1) DK0624375T3 (sv)
ES (1) ES2176222T3 (sv)
FI (1) FI940726A (sv)
GB (1) GB9303275D0 (sv)
HU (1) HUT66079A (sv)
IL (1) IL108610A (sv)
MX (1) MX9401244A (sv)
NO (1) NO940551D0 (sv)
NZ (1) NZ250895A (sv)
PH (1) PH30338A (sv)
PT (1) PT624375E (sv)
TW (1) TW315303B (sv)
ZA (1) ZA941087B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
KR20000070338A (ko) * 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
NO20013182L (no) 2000-06-26 2001-12-27 Nokian Tyres Plc System og fremgangsmåte for konvertering og overföring av driftsdata for dekk
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487600A (en) * 1945-10-09 1949-11-08 Sharp & Dohme Inc Aqueous thixotropic gel composition
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
US2987600A (en) * 1959-03-11 1961-06-06 Corning Glass Works Capacitor edge sealing
CA1340646C (en) * 1987-05-21 1999-07-13 John L. Krstenansky Cyclic anticoagulant peptides
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
NO940551L (sv) 1994-08-19
CN1108137A (zh) 1995-09-13
NZ250895A (en) 1994-06-27
EP0624375A2 (en) 1994-11-17
FI940726A (sv) 1994-08-19
ATE216586T1 (de) 2002-05-15
TW315303B (sv) 1997-09-11
AU5508394A (en) 1994-08-25
DE69430458T2 (de) 2002-11-21
IL108610A (en) 1998-03-10
PH30338A (en) 1997-04-02
PT624375E (pt) 2002-08-30
HU9400458D0 (en) 1994-05-30
US5472938A (en) 1995-12-05
IL108610A0 (en) 1994-08-26
CA2115815A1 (en) 1994-08-19
EP0624375B1 (en) 2002-04-24
AU675471B2 (en) 1997-02-06
JPH06256214A (ja) 1994-09-13
MX9401244A (es) 1994-08-31
DK0624375T3 (da) 2002-07-29
ZA941087B (en) 1994-08-18
ES2176222T3 (es) 2002-12-01
NO940551D0 (no) 1994-02-17
GB9303275D0 (en) 1993-04-07
JP3649343B2 (ja) 2005-05-18
EP0624375A3 (en) 1995-07-19
DE69430458D1 (de) 2002-05-29
HUT66079A (en) 1994-09-28

Similar Documents

Publication Publication Date Title
MX9202413A (es) Composiciones acuosas de citrato de calcio.
SE8303696D0 (sv) Farmakologiska kompositioner
MX9401244A (es) Composiciones farmaceuticas.
DE69506903D1 (de) Erhöhte solubiliierung von komplexsalzen von methionin mit zink und mangan durch zusatz von ferriionen
HU9500216D0 (en) Stable dry powdevs
CA2066532A1 (en) Pharmaceutical compositions
ATE68973T1 (de) Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts.
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
MY113686A (en) Fungicide mixtures

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG